Physician profile
Jacquelyn Mcdowell
NPI 1326373820
$670.05
in general payments reported to CMS, 2019-2025
12 companies · $355 in 2025
The $355 reported for 2025 was more than what 88% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.20 · 2023: $13.91 · 2024: $271 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $100.61 | 2025 | Jornay Pm |
| Corium, LLC | $98.67 | 2024-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $98.05 | 2024 | |
| Seqirus USA INC | $77.84 | 2024-2025 | Flucelvax |
| Merck Sharp & Dohme LLC | $63.43 | 2021-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Galderma Laboratories, L.P. | $61.76 | 2024-2025 | |
| Cranial Technologies, INC | $50.69 | 2024-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $48.75 | 2024-2025 | |
| Glaxosmithkline, LLC. | $20.86 | 2025 | Penmenvy, Bexsero |
| Eyevance Pharmaceuticals LLC | $17.99 | 2021 | |
| Verrica Pharmaceuticals INC. | $17.49 | 2024 | Ycanth |
| Supernus Pharmaceuticals, INC. | $13.91 | 2023 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Mcdowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.